Fish oil is one of the most popular supplements in the world, and most people take it for heart health or to reduce inflammation. But there’s a growing body of research suggesting omega-3 fatty acids do something else worth paying attention to: they appear to stimulate GLP-1 release from the gut. That’s a different mechanism than most people associate with fish oil, and it puts omega-3s in an interesting position as part of a natural metabolic support plan.
The research here is more directly relevant to GLP-1 than the evidence for chromium, cinnamon, or inositol. It’s not as strong as berberine’s track record, but it’s real and worth understanding — especially because omega-3s come with a long list of additional metabolic benefits that make them useful regardless of their GLP-1 effects.
How Omega-3 Fatty Acids Interact with GLP-1
GLP-1 is released by L-cells in the small intestine and colon when they detect nutrients passing through. Different macronutrients trigger different amounts of GLP-1 release — and fats, particularly certain types of fat, are among the stronger stimulators.
Omega-3 fatty acids — specifically EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), the two main active forms found in fish oil — appear to stimulate L-cells through a receptor called GPR120 (also known as free fatty acid receptor 4, or FFAR4). When EPA and DHA bind to GPR120 on L-cells, they trigger GLP-1 secretion. This is a direct molecular pathway, not just an indirect or theoretical connection.
Animal studies have shown this effect clearly and consistently. Human studies are fewer, but several have found measurable increases in GLP-1 following omega-3 supplementation, particularly in people with metabolic dysfunction. A study published in the Journal of Nutrition found that fish oil supplementation increased postprandial (after-meal) GLP-1 levels in overweight adults compared to a control group. The effect wasn’t enormous, but it was statistically meaningful.
The GPR120 Receptor: Why It Matters
GPR120 is worth understanding because it explains why the type of fat matters — not just the amount. Saturated fats don’t activate GPR120 the way omega-3s do. Omega-6 fatty acids (found abundantly in vegetable oils) activate it weakly. Long-chain omega-3s like EPA and DHA are among the strongest natural activators of this receptor.
GPR120 also plays a role in reducing inflammation and improving insulin sensitivity, which means omega-3s are working on GLP-1 and metabolic health through the same receptor simultaneously. This overlap is one reason fish oil tends to show broad metabolic benefits in trials rather than a single isolated effect.
Omega-3s and Inflammation: The Indirect GLP-1 Pathway
Beyond direct L-cell stimulation, omega-3s may support GLP-1 activity through a second pathway: reducing chronic low-grade inflammation.
Chronic inflammation — the kind that simmers in the background without causing obvious symptoms — is closely linked to insulin resistance and metabolic dysfunction. It also appears to blunt GLP-1 signaling over time. Inflammatory compounds called cytokines can interfere with the pancreatic beta cells that respond to GLP-1, reducing the insulin secretion that GLP-1 is supposed to trigger.
EPA and DHA are converted in the body into anti-inflammatory compounds called resolvins and protectins. These molecules actively help resolve inflammatory processes rather than just suppressing them temporarily. By lowering the inflammatory burden on metabolic tissue, omega-3s may help restore GLP-1’s effectiveness in people whose signaling has been blunted by years of metabolic stress.
Omega-3s and the Gut Microbiome
There’s a third pathway that’s newer in the research but increasingly relevant: omega-3s appear to positively influence the gut microbiome — the community of bacteria living in your intestines. Since the gut microbiome plays a direct role in GLP-1 production through the fermentation of fiber into short-chain fatty acids (SCFAs) that stimulate L-cells, anything that supports a healthier microbiome composition has downstream implications for GLP-1.
Studies have found that omega-3 supplementation increases populations of beneficial bacteria like Bifidobacterium and Lactobacillus, both of which are associated with improved metabolic function and GLP-1 support. This connects omega-3s to the same gut-health story covered in the articles on probiotics and gut health and GLP-1.
What the Human Evidence Actually Shows
It’s worth being clear about the state of the evidence. The direct GLP-1-stimulating effect of omega-3s has been demonstrated more convincingly in animal models than in large human trials. Human studies do exist and show positive signals, but they tend to be smaller, shorter, and more variable in their findings.
Where the human evidence is stronger is in omega-3s’ effects on the broader metabolic picture: triglyceride reduction, inflammation markers, insulin sensitivity, and cardiovascular risk. These benefits are well-established across large trials and meta-analyses. The GLP-1 effect is a plausible and supported additional mechanism, but it shouldn’t be the sole reason you take fish oil.
Think of it this way: if you’re taking omega-3s for heart health and inflammation, you’re likely getting GLP-1 support as a bonus. If you’re taking them specifically to spike GLP-1, berberine and soluble fiber have a more direct and better-established track record for that specific goal.
EPA vs. DHA: Does the Ratio Matter?
Most fish oil supplements contain both EPA and DHA, but the ratio varies by product. For the GLP-1 and metabolic health angle, EPA appears to be the more relevant compound — it has stronger effects on inflammation and GPR120 activation in most studies. DHA is more important for brain health and neurological function.
That said, separating them completely isn’t practical for most people, and combined EPA/DHA supplements have shown metabolic benefits in trials. A product with a higher EPA-to-DHA ratio (such as 2:1 or 3:1 EPA to DHA) may be marginally preferable for metabolic purposes, but it’s not a critical distinction for most people at standard supplemental doses.
Choosing a Fish Oil Supplement: What Actually Matters
Fish oil quality varies enormously. Oxidation — the process by which fish oil goes rancid — is a genuine problem with lower-quality products, and oxidized fish oil may actually promote inflammation rather than reduce it. Here’s what to look for.
Total EPA + DHA content: This is the number that matters, not the total fish oil amount. A 1,000 mg fish oil softgel might contain only 300 mg of combined EPA and DHA. Most clinical trials showing metabolic benefits used 1,000 to 4,000 mg of combined EPA and DHA per day, not 1,000 mg of fish oil. Read the supplement facts panel carefully.
Molecular distillation: Look for products that have been molecularly distilled to remove heavy metals, PCBs, and other contaminants. This should be stated on the label or the manufacturer’s website.
Third-party testing: Products certified by organizations like IFOS (International Fish Oil Standards) or NSF International have been independently tested for purity and potency. This matters more for fish oil than many other supplements because of the contamination and oxidation risks.
Triglyceride vs. ethyl ester form: Fish oil comes in two main chemical forms. The triglyceride form is better absorbed — some studies suggest 70% better than the ethyl ester form, which is cheaper to produce and more common in budget supplements. Re-esterified triglyceride products are even better absorbed than natural triglyceride form. Premium products will specify which form they use.
How Much to Take
For general health, most guidelines suggest 250 to 500 mg of combined EPA and DHA per day. For metabolic support and the GLP-1-related benefits discussed here, the trials showing effects on inflammation, insulin sensitivity, and GLP-1 typically used 1,000 to 3,000 mg of combined EPA and DHA daily.
Taking fish oil with your largest meal of the day improves absorption and reduces the fishy aftertaste or “fish burps” that some people experience. Keeping fish oil in the refrigerator also slows oxidation and improves tolerability.
Practical Takeaway: Omega-3s as Part of a GLP-1 Support Plan
Omega-3 fatty acids earn their place in a natural GLP-1 support plan — not as a single-purpose GLP-1 booster, but as a supplement with multiple overlapping metabolic benefits, one of which includes supporting GLP-1 secretion through the GPR120 pathway. They also reduce the inflammation that can blunt GLP-1 signaling and support the gut microbiome that drives GLP-1 production.
If you’re already taking fish oil for cardiovascular health, you’re likely getting these metabolic benefits too. If you’re not already taking it, adding a high-quality product with 1,000 to 2,000 mg of combined EPA and DHA daily is a reasonable step — particularly if you have signs of insulin resistance, elevated triglycerides, or chronic inflammation.
Omega-3s pair well with berberine and fiber-based supplements that stimulate GLP-1 more directly. Together, they address both the trigger (L-cell stimulation) and the environment (inflammation, gut health, insulin sensitivity) that determines how well your GLP-1 system functions. For a full picture of how to combine these approaches, see The Best Supplement Stack for Natural GLP-1 Support.